Skip to main content

Table 1 Correlation analysis between clinical characteristics and anesthetics

From: Uncovering essential anesthetics-induced exosomal miRNAs related to hepatocellular carcinoma progression: a bioinformatic investigation

Parameter

propofol

sevoflurane

p-value

Age (yr)*

50(43.5–51.5)

44(36-54.5)

0.594

Body mass index (kg/m2)*

20.8(19.4–24.2)

21.3(19.4–26.6)

0.642

ASA Physical Status (I/II)

2/3

2/3

1.000

Tumor size (cm3)*#

9.8(2.1–49.3)

16.4(6.6–31.7)

0.490

Tumor stage (I/II/III)†

0/4/1

0/4/1

1.000

BCLC stage (0/A/B/C/D)§

0/5/0/0/0

0/5/0/0/0

1.000

Inflammatory grade by Scheuer scoring system (1/2)

1/4

2/3

0.513

Fibrotic stage by Scheuer scoring system (1/2/3/4)

0/0/2/3

1/0/2/2

0.419

HBV infection (yes/no)

5/0

5/0

1.000

Anti-viral treatments to HBV (yes/no)

3/2

2/3

0.500

Liver stiffness measurement by liver B-ultrasound (kPa)*

12.8(11.0-14.2)

11.8(7.5–16.4)

0.756

Preoperative platelet count (×109/L)*

150(124–164)

204(118–247)

0.253

Preoperative AFP level (ng/mL)*

667(180–3147)

32(4-415)

0.117

  1. *Data are median (p25 – p75). ASA, American Society of Anesthesiologists; HBV, hepatitis B virus; AFP, alpha-fetoprotein. #Tumor size (cm3)=π/6×length(cm)×width(cm)×heigth(cm). †The Edmondson-Steiner grading system for HCC. §The Barcelona Clinic Liver Cancer (BCLC) staging system